What are Merck & Co.'s total assets?

Merck & Co. (MRK) holds $128.69B in total assets, up 11.8% year over year.

How much debt does Merck & Co. have?

Merck & Co. carries $49.1B in total debt against $45.9B of shareholders' equity, a debt-to-equity ratio of 1.07.

How much cash does Merck & Co. have?

Merck & Co. holds $5.4B in cash and equivalents.

Can Merck & Co. cover its short-term obligations?

Its current ratio is 1.30 — current assets exceed current liabilities.

Where does Merck & Co.'s balance sheet data come from?

Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Merck & Co. MRK Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$5.4B-38.2%	$14.69B+10.3%	$18.26B+24.3%	$8.07B-29.0%	$8.73B+54.0%
Short-term investments	$375M-37.4%	$0-100%	$45M—	$615M+1,130%	$599M+1,398%
Restricted cash	$71M-31.1%	$125M+64.5%	$91M-4.2%	$66M-4.3%	$103M+12.0%
Accounts receivable, net	$12.21B+13.2%	$11.78B+14.6%	$12.12B+6.5%	$11.85B+1.8%	$10.79B-5.1%
Inventories	$6.2B+36.0%	$5.68B+35.5%	$5.41B+35.5%	$4.88B+41.3%	$4.56B+33.5%
Finished goods	$2.21B+3.9%	$2.28B+12.5%	$2.25B+16.0%	$2.14B+13.4%	$2.13B+11.9%
Income taxes receivable	——	——	——	——	——
Derivative assets	$562M+37.1%	$323M-55.7%	$316M-7.1%	$546M+11.2%	$410M+14.8%
Materials and supplies	$334M+15.2%	$331M+14.5%	$325M+15.2%	$312M+16.9%	$290M+5.1%
Total current assets	$35.02B-1.4%	$43.52B+12.2%	$47.56B+17.8%	$37.07B-3.0%	$35.5B+12.9%
Property and equipment, net	$25.43B+2.6%	$25.32B+6.5%	$25.64B+9.4%	$25.24B+8.7%	$24.79B+7.6%
Land	——	——	——	——	——
Buildings and improvements	——	——	——	——	——
Machinery and equipment	——	——	——	——	——
Construction in progress	——	——	——	——	——
Accumulated depreciation	$22.29B+13.3%	$21.91B+14.4%	$20.61B+8.0%	$20.26B+6.8%	$19.68B+5.7%
Goodwill	$21.58B-0.5%	$21.58B-0.4%	$21.59B-0.5%	$21.59B+2.0%	$21.68B+2.4%
Deferred tax assets	-$315M-122%	$6.73B+27.8%	$1.38B+59.8%	$1.43B+62.9%	$1.41B+52.8%
Long-term investments	——	——	——	——	——
Equity securities	$1.57B+52.1%	$1.39B+51.3%	$1.55B+57.1%	$1.18B+15.1%	$1.03B+13.8%
Total assets	$128.69B+11.8%	$136.87B+16.9%	$129.55B+10.2%	$117.52B+4.3%	$115.12B+8.8%
Accounts payable	$3.86B+2.1%	$4.4B+8.0%	$4.15B+15.6%	$3.89B+10.6%	$3.78B+7.7%
Dividends payable	$2.14B+3.2%	$2.14B+2.7%	$2.04B+3.0%	$2.05B+3.6%	$2.08B+3.4%
Total current liabilities	$26.95B+7.0%	$28.33B-0.3%	$28.63B-3.2%	$26.04B-0.1%	$25.17B+0.3%
Deferred tax liabilities	——	——	——	——	——
Long-term debt	$49.1B+41.1%	$49.3B+32.9%	$41.4B+8.7%	$35.4B-6.3%	$34.8B+1.8%
Other non-current liabilities	$7.64B+14.8%	$7.69B+18.9%	$7.66B+1.6%	$7.03B-4.1%	$6.66B-19.5%
Total liabilities	——	——	——	——	——
Retained earnings	$66.72B+0.9%	$73.08B+15.9%	$72.23B+17.7%	$68.48B+13.8%	$66.1B+16.6%
Accumulated other comprehensive income (loss)	-$4.06B+18.2%	-$4.29B+13.3%	-$5.2B+3.1%	-$5.42B-1.1%	-$4.97B+5.9%
Treasury stock	$63.75B+7.3%	$63B+8.1%	$61.8B+6.9%	$60.5B+5.4%	$59.4B+3.4%
Total stockholders' equity	$45.88B-5.1%	$52.61B+13.6%	$51.85B+16.5%	$48.99B+12.4%	$48.34B+19.7%
Total liabilities and stockholders' equity	$128.69B+11.8%	$136.87B+16.9%	$129.55B+10.2%	$117.52B+4.3%	$115.12B+8.8%
Allowance for Doubtful Accounts	$103M+10.8%	$97M+9.0%	$93M+17.7%	$94M+14.6%	$93M+16.3%
Contract Assets, Net	——	——	——	——	——
Short- term Investments	$375M-37.4%	$0-100%	$45M—	$615M+1,130%	$599M—
Other current assets	$10.62B+14.4%	$10.52B+20.8%	$10.78B+32.4%	$10B+14.4%	$9.29B—
Derivative Assets - Fair Value	$562M+37.1%	$323M-55.7%	$316M-7.1%	$546M+11.2%	$410M—
Other Inventory, Net	——	——	——	——	——
Trading Securities in Marketable Securities	$881M+1.0%	$831M-3.7%	$834M-1.7%	$870M-7.1%	$872M+2.5%
Accumulated Goodwill Impairment Losses	——	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$19.81B+18.1%	$1.24B+54.1%	$18.33B+26.9%	$17.66B+39.1%	$16.77B+36.0%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$881M+1.0%	$831M-3.7%	$834M-1.7%	$870M-7.1%	$872M+2.5%
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments	$320M+3.6%	$292M-5.5%	$293M-3.0%	$307M-13.5%	$309M+4.0%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Indefinite-Lived Research and Development Assets	——	——	——	——	——
Intangible Assets Gross (Excluding Goodwill)	——	——	——	——	——
Investments - Amortized Cost Basis	$881M+1.0%	$831M-3.7%	$834M-1.7%	$870M-7.1%	$872M+2.5%
Net Operating Loss Carryforwards	——	——	——	——	——
Other intangible assets—net	$25.75B+63.4%	$26.68B+63.0%	$15.31B-10.0%	$15.19B-10.5%	$15.76B-10.3%
Investments	——	——	——	——	——
Machinery and equipment	——	——	——	——	——
Long- term Investments	$1.11B+79.4%	$956M+106%	$1.12B+94.3%	$774M+117%	$616M+120%
Other non-current assets	$19.81B+18.1%	$18.82B+17.3%	$18.33B+26.9%	$17.66B+39.1%	$16.77B—
Property, plant and equipment at cost	——	——	——	——	——
Software and Technology Licenses, Net	$19.81B+18.1%	$18.82B+17.3%	$18.33B+26.9%	$17.66B+39.1%	$16.77B—
Tax Credit Carryforward Valuation Allowance	——	——	——	——	——
Accrued Environmental Liabilities	——	——	——	——	——
Accrued Income Taxes, Current	$3.95B-23.8%	$4.73B+20.7%	$4.85B+12.0%	$4.16B+49.7%	$5.18B+116%
Other accrued liabilities	$14.55B+13.9%	$14.47B-7.8%	$16.19B-2.1%	$14.5B-1.4%	$12.77B-9.4%
Derivative Liabilities - Fair Value	$225M-5.9%	$245M-18.1%	$246M+9.3%	$445M+290%	$239M+115%
Derivative Liabilities - Not Offset Policy Election Deduction	$225M-5.9%	$245M-18.1%	$246M+9.3%	$445M+290%	$239M+115%
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Sales Rebates and Discounts	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Deferred Tax Liabilities - Foreign Earnings	——	——	——	——	——
Secured Borrowings Cash Right to Reclaim	$0—	$0—	$0—	$97M—	$0—
Unrecognized Tax Benefits	——	——	——	——	——
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	——	——	——	——
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	——	——	——	——	——
Common Stock Shares Outstanding	——	——	——	——	——
Convertible Preferred Stock Authorized Shares	——	——	——	——	——
Cumulative Gross Losses and Impairments	——	——	——	——	——
Additional paid-in capital	$45.18B+0.8%	$45.03B+0.7%	$44.83B+0.7%	$44.64B+0.6%	$44.82B+0.5%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$1.79B0.0%	$1.79B0.0%	$1.79B0.0%	$1.79B0.0%	$1.79B0.0%
Number of Exercisable Options	——	——	——	——	——
Number of Vested and Expected to Vest Options	——	——	——	——	——
Shares Reserved for Future Issuance Under Stock Plans	——	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	——	——	——	——	——
Weighted Average Exercise Price of Vested and Expected to Vest Options	——	——	——	——	——
Aggregate Notional Principal Outstanding	$42.11B-0.6%	$40.29B+4.5%	$42.87B+21.4%	$44.69B+35.0%	$42.36B+31.5%
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)	-$69M-531%	-$178M-168%	-$298M-85.1%	-$473M-349%	$16M—
Gross Assets/Liabilities	$229M-14.6%	$324M-6.1%	$492M+65.1%	$855M+502%	$268M+60.5%
Long-term debt interest payments - 2024	——	——	——	——	——
Long-term debt interest payments - 2025	——	——	——	——	——
Long-term debt interest payments - 2026	——	——	——	——	——
Accrual for Environmental Loss Contingencies	——	——	——	——	——
Allowance for doubtful accounts	$103M+10.8%	$97M+9.0%	$93M+17.7%	$94M+14.6%	$93M+16.3%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$0—	$0—	$0—	$0—	$0—
Gross Unrealized Gains	$0—	$0—	$0—	$0—	$0—
Total	$476M-31.0%	$101M-81.2%	$145M+79.0%	$707M+457%	$690M+490%
Available for sale investments	$476M-31.0%	$101M-81.2%	$145M+79.0%	$707M+457%	$690M+490%
Common stock, par value (in dollars per share)	$0.500.0%	$0.500.0%	$0.500.0%	$0.500.0%	$0.500.0%
Common stock, shares authorized (in shares)	6.5B0.0%	6.5B0.0%	6.5B0.0%	6.5B0.0%	6.5B0.0%
Common stock, shares issued (in shares)	3.6B0.0%	3.6B0.0%	3.6B0.0%	3.6B0.0%	3.6B0.0%
Construction work in progress	——	——	——	——	——
Short-term debt and current portion of long-term debt	$2.44B+79.7%	$2.59B-2.3%	$1.41B-55.4%	$1.43B-53.3%	$1.36B-55.8%
Debt Instrument, Fair Value Disclosure	$44.7B+46.1%	$45.6B+39.9%	$37.7B+7.1%	$31.3B-6.6%	$30.6B+0.7%
Debt Securities and Equity Securities, FV-NI	$2.05B+18.8%	$1.49B+2.5%	$1.69B+58.8%	$1.89B+63.7%	$1.72B+68.1%
Deferred Tax Liabilities, Gross	——	——	——	——	——
Deferred income taxes	$1.49B+6.0%	$1.44B+3.7%	$1.38B+59.8%	$1.43B+62.9%	$1.41B+52.8%
Deferred Tax Assets, Goodwill and Intangible Assets	——	——	——	——	——
Deferred Tax Assets, Gross	——	——	——	——	——
Deferred Tax Assets, Net	——	——	——	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	——	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits	——	——	——	——	——
Deferred Tax Assets, Valuation Allowance	——	——	——	——	——
Federal and state intangible assets	——	——	——	——	——
Deferred Tax Liabilities, Other	——	——	——	——	——
Deferred Tax Liabilities, Property, Plant and Equipment	——	——	——	——	——
Derivative Asset, Subject to Master Netting Arrangement, after Offset	$248M+67.6%	$77M-70.9%	$69M-40.0%	$97M-61.8%	$148M—
Potential reduction in net position of total derivative assets	——	——	——	——	——
Margin cash collateral received from counterparties that was not offset against derivative assets	——	——	——	——	——
Margin cash collateral provided to counterparties that was not offset against derivative assets or liabilities	——	——	——	——	——
Derivative, gross, assets	$562M+37.1%	$323M-55.7%	$316M-7.1%	$546M+11.2%	$410M—
Derivatives, gross, liabilities	$229M-14.6%	$324M-6.1%	$492M+65.1%	$855M+502%	$268M—
Derivative Liability	$229M-14.6%	$324M-6.1%	$492M+65.1%	$855M+502%	$268M+60.5%
Derivative Liability, Subject to Master Netting Arrangement, after Offset	$4M-86.2%	$79M+71.7%	$246M+237%	$313M+1,018%	$29M—
Potential reduction in net position of total derivative liabilities	$225M-5.9%	$245M-18.1%	$246M+9.3%	$445M+290%	$239M+115%
Notional	$42.11B-0.6%	$40.29B+4.5%	$42.87B+21.4%	$44.69B+35.0%	$42.36B+31.5%
Trading securities, cost	$881M+1.0%	$831M-3.7%	$834M-1.7%	$870M-7.1%	$872M+2.5%
Finite-Lived Intangible Assets, Accumulated Amortization	——	——	——	——	——
2028	——	——	——	——	——
2030	——	——	——	——	——
2031	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Goodwill accumulated impairment losses	——	——	——	——	——
Carrying values of hedged liabilities	——	——	——	——	——
Cumulative amount of fair value hedging adjustment	——	——	——	——	——
Indefinite- lived intangible impairment	——	——	——	——	——
Inventory, LIFO Reserve	——	——	——	——	——
Inventory Net And Inventory Noncurrent	$12.67B+17.9%	$12.34B+19.8%	$11.86B+15.8%	$11.48B+15.7%	$10.75B+8.4%
Raw materials and work in process	$11.14B+21.3%	$10.65B+20.5%	$10.17B+15.8%	$9.89B—	$9.18B—
Committed Revolving Credit Facilities	——	——	——	——	——
2028	——	——	——	——	——
2029	——	——	——	——	——
2029	——	——	——	——	——
2030	——	——	——	——	——
2027	——	——	——	——	——
Noncontrolling interests in subsidiaries	$53M-18.5%	$56M-5.1%	$57M-1.7%	$67M+1.5%	$65M+8.3%
Other financial assets	——	——	——	——	——
Preferred Stock, Shares Authorized	——	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	——	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	——	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	——	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	——	——	——	——	——
Incentive stock program, shares reserved for future grants (in shares)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——	——
Stockholders' Equity before Treasury Stock	$109.63B+1.8%	$115.61B+10.5%	$113.65B+11.1%	$109.49B+8.4%	$107.74B+10.1%
Tax Cuts and Jobs Act payment	——	——	——	——	——
Treasury stock, shares (in shares)	1.1B+4.4%	1.1B+5.1%	1.1B+4.3%	1.1B+3.1%	1.1B+1.6%
Unrecognized tax benefits	——	——	——	——	——
Penalties and interest accrued on unrecognized tax benefits	——	——	——	——	——
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Merck & Co..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Merck & Co.'s total assets?: Merck & Co. (MRK) holds $128.69B in total assets, up 11.8% year over year.
How much debt does Merck & Co. have?: Merck & Co. carries $49.1B in total debt against $45.9B of shareholders' equity, a debt-to-equity ratio of 1.07.
How much cash does Merck & Co. have?: Merck & Co. holds $5.4B in cash and equivalents.
Can Merck & Co. cover its short-term obligations?: Its current ratio is 1.30 — current assets exceed current liabilities.
Where does Merck & Co.'s balance sheet data come from?: Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.